All Stories

  1. Diabetes management strategies: can nanoparticles be used to therapeutically deliver insulin?

    Article • Therapeutic Delivery, February 2017, Future Science

    Dr Serena Mazzucchelli

  2. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats

    Article • Pharmacological Research, August 2016, Elsevier

    Dr Serena Mazzucchelli

  3. Antiretroviral Therapy through Barriers: A Prominent Role for Nanotechnology in HIV-1 Eradication from Sanctuaries

    Article • Journal of Pharmacy and Pharmacology, July 2016, David Publishing Company

    Dr Serena Mazzucchelli

  4. Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer

    Article • Pharmacological Research, May 2016, Elsevier

    Dr Serena Mazzucchelli

  5. The potential of protein-based nanocages for imaging and drug delivery

    Article • Therapeutic Delivery, March 2016, Future Science

    Dr Serena Mazzucchelli

  6. What Is the Role of Nanotechnology in Diagnosis and Treatment of Metastatic Breast Cancer? Promising Scenarios for the Near Future

    Article • Journal of Nanomaterials, January 2016, Hindawi Publishing Corporation

    Dr Serena Mazzucchelli

  7. Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice

    Article • Nanomedicine Nanotechnology Biology and Medicine, August 2015, Elsevier

    Dr Serena Mazzucchelli

  8. Peptide-Nanoparticle Ligation Mediated by Cutinase Fusion for the Development of Cancer Cell-Targeted Nanoconjugates

    Article • Bioconjugate Chemistry, April 2015, American Chemical Society (ACS)

    Dr Serena Mazzucchelli

  9. Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells

    Article • Journal of Controlled Release, December 2014, Elsevier

    Dr Serena Mazzucchelli

  10. Development of U11-Functionalized Gold Nanoparticles for Selective Targeting of Urokinase Plasminogen Activator Receptor-Positive Breast Cancer Cells

    Article • Bioconjugate Chemistry, August 2014, American Chemical Society (ACS)

    Dr Serena Mazzucchelli

  11. Antiproliferative Effect of ASC-J9 Delivered by PLGA Nanoparticles against Estrogen-Dependent Breast Cancer Cells

    Article • Molecular Pharmaceutics, July 2014, American Chemical Society (ACS)

    Dr Serena Mazzucchelli

  12. Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome

    Article • The International Journal of Biochemistry & Cell Biology, June 2014, Elsevier

    Dr Serena Mazzucchelli

  13. Delivering Colloidal Nanoparticles to Mammalian Cells: A Nano-Bio Interface Perspective

    Article • Advanced Healthcare Materials, January 2014, Wiley

    Dr Serena Mazzucchelli

  14. Targeted approaches for HER2 breast cancer therapy: News from nanomedicine?

    Article • World Journal of Pharmacology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Serena Mazzucchelli

  15. Assessing the In Vivo Targeting Efficiency of Multifunctional Nanoconstructs Bearing Antibody-Derived Ligands

    Article • ACS Nano, July 2013, American Chemical Society (ACS)

    Dr Serena Mazzucchelli

  16. O 6 -alkylguanine-DNA transferase (SNAP) as capture module for site-specific covalent bioconjugation of targeting protein on nanoparticles

    Article • February 2013, SPIE

    Dr Serena Mazzucchelli

  17. Orientation-Controlled Conjugation of Haloalkane Dehalogenase Fused Homing Peptides to Multifunctional Nanoparticles for the Specific Recognition of Cancer Cells

    Article • Angewandte Chemie International Edition, February 2013, Wiley

    Dr Serena Mazzucchelli

  18. Orientation-Controlled Conjugation of Haloalkane Dehalogenase Fused Homing Peptides to Multifunctional Nanoparticles for the Specific Recognition of Cancer Cells

    Article • Angewandte Chemie, February 2013, Wiley

    Dr Serena Mazzucchelli

  19. Dependence of nanoparticle-cell recognition efficiency on the surface orientation of scFv targeting ligands

    Article • Biomaterials Science, January 2013, Royal Society of Chemistry

    Dr Serena Mazzucchelli

  20. Rücktitelbild: Protein-Assisted One-Pot Synthesis and Biofunctionalization of Spherical Gold Nanoparticles for Selective Targeting of Cancer Cells (Angew. Chem. 37/2012)

    Article • Angewandte Chemie, August 2012, Wiley

    Dr Serena Mazzucchelli

  21. Back Cover: Protein-Assisted One-Pot Synthesis and Biofunctionalization of Spherical Gold Nanoparticles for Selective Targeting of Cancer Cells (Angew. Chem. Int. Ed. 37/2012)

    Article • Angewandte Chemie International Edition, August 2012, Wiley

    Dr Serena Mazzucchelli

  22. Protein-Assisted One-Pot Synthesis and Biofunctionalization of Spherical Gold Nanoparticles for Selective Targeting of Cancer Cells

    Article • Angewandte Chemie, July 2012, Wiley

    Dr Serena Mazzucchelli

  23. Protein-Assisted One-Pot Synthesis and Biofunctionalization of Spherical Gold Nanoparticles for Selective Targeting of Cancer Cells

    Article • Angewandte Chemie International Edition, July 2012, Wiley

    Dr Serena Mazzucchelli

  24. Protein Oriented Ligation on Nanoparticles Exploiting O6-Alkylguanine-DNA Transferase (SNAP) Genetically Encoded Fusion

    Article • Small, March 2012, Wiley

    Dr Serena Mazzucchelli

  25. Site-Specific Conjugation of ScFvs Antibodies to Nanoparticles by Bioorthogonal Strain-Promoted Alkyne-Nitrone Cycloaddition

    Article • Angewandte Chemie, November 2011, Wiley

    Dr Serena Mazzucchelli

  26. Site-Specific Conjugation of ScFvs Antibodies to Nanoparticles by Bioorthogonal Strain-Promoted Alkyne-Nitrone Cycloaddition

    Article • Angewandte Chemie International Edition, November 2011, Wiley

    Dr Serena Mazzucchelli

  27. Multiple Presentation of Scfv800E6 on Silica Nanospheres Enhances Targeting Efficiency Toward HER-2 Receptor in Breast Cancer Cells

    Article • Bioconjugate Chemistry, November 2011, American Chemical Society (ACS)

    Dr Serena Mazzucchelli

  28. HER2 Expression in Breast Cancer Cells Is Downregulated Upon Active Targeting by Antibody-Engineered Multifunctional Nanoparticles in Mice

    Article • ACS Nano, August 2011, American Chemical Society (ACS)

    Dr Serena Mazzucchelli

  29. Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells

    Article • Applied Microbiology and Biotechnology, May 2011, Springer Science + Business Media

    Dr Serena Mazzucchelli

  30. Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles

    Article • Nanoscale, January 2011, Royal Society of Chemistry

    Dr Serena Mazzucchelli

  31. Single-Domain Protein A-Engineered Magnetic Nanoparticles: Toward a Universal Strategy to Site-Specific Labeling of Antibodies for Targeted Detection of Tumor Cells

    Article • ACS Nano, October 2010, American Chemical Society (ACS)

    Dr Serena Mazzucchelli

  32. Towards a Universal Method for the Stable and Clean Functionalization of Inert Perfluoropolymer Nanoparticles: Exploiting Photopolymerizable Amphiphilic Diacetylenes

    Article • Advanced Functional Materials, September 2010, Wiley

    Dr Serena Mazzucchelli, Professor Marco Buscaglia

  33. HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches

    Article • Pharmacological Research, August 2010, Elsevier

    Dr Serena Mazzucchelli

  34. Magnetofluorescent nanoparticles for bimodal detection of breast cancer cells

    Article • January 2010, American Institute of Physics

    Dr Serena Mazzucchelli

  35. Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin

    Article • The International Journal of Biochemistry & Cell Biology, December 2009, Elsevier

    Dr Serena Mazzucchelli